InnoCare Pharma Limited 09969.HK 价格预测与展望

Q: 技术分析指标如何适用于 09969.HK？

根据技术分析，InnoCare Pharma Limited 的综合信号为 Sell。InnoCare Pharma Limited 有 1 个买入信号，2 个中性信号和 4 个卖出信号。

Q: 09969.HK 的斐波那契回调水平是多少？

InnoCare Pharma Limited 的斐波那契回调水平是 低于100%的水平。

Q: InnoCare Pharma Limited 的 RSI 是多少？

InnoCare Pharma Limited 的 RSI 目前为 30.17，表明处于 中立 状态

Q: InnoCare Pharma Limited 接下来 12 个月的价格是多少？

InnoCare Pharma Limited 09969.HK 接下来 12 个月的价格预计为 $0。

Q: InnoCare Pharma Limited 预计会涨到多高？

据华尔街分析师称，InnoCare Pharma Limited 预计将达到 $0 的高预测值。

主页

股票

09969.HK

预测

INNOCARE (09969.HK)

InnoCare Pharma Limited

HK$12.21

-2.47%

$-0.3

休市： Jan 20, 16:00:00 HKT

关键数据

前收盘价

$12.33

开盘价

$12.52

当日区间

$12.13 - $12.52

52周范围

$5.02 - $20.62

交易量

1.7M

平均成交量

9.1M

每股收益（TTM）

-0.13

股息收益率

市值

$18.2B

什么是 INNOCARE？

InnoCare Pharma Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 1,146 full-time employees. The company went IPO on 2020-03-23. InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The firm focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The firm's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The firm is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The firm conducts its businesses in domestic and overseas markets.

功能特性

交易策略

资源

市场

09969.HK 股价预测摘要

09969.HK stock price ended at $12.35 on 星期二, after rising 0.16%

On the latest trading day Jan 20, 2026, the stock price of 09969.HK rose by 0.16%, climbing from $12.52 to $12.35. Throughout the session, the stock experienced a volatility of 2.37%, with prices fluctuating between a daily low of $12.23 and a high of $12.52. Alongside this price increase, trading volume also rose by 7.0M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 180.0K shares were traded, amounting to a market value of approximately $18.4B.

09969.HK 技术面信号

技术面信号摘要

购买信号 1

中性信号 2

卖出信号 4

Strong Sell

Sell

Neutral

Buy

Strong Buy

09969.HK目前显示1个买入信号和4个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为0.16%。总体而言，技术指标显示中期前景为Sell。

09969.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 09969.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 09969.HK？



09969.HK 的斐波那契回调水平是多少？



InnoCare Pharma Limited 的 RSI 是多少？



InnoCare Pharma Limited 接下来 12 个月的价格是多少？



InnoCare Pharma Limited 预计会涨到多高？



InnoCare Pharma Limited（09969.HK）价格

09969.HK 股价走势图